The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D 3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells

Clinical Cancer Research

Volumn 14, Issue 11, 2008, Pages 3562-3570

  Myrthue, Anne ^a   Rademacher, Brooks L S ^a   Pittsenbarger, Janet ^a   Kutyba Brooks, Bozena ^a   Gantner, Marin ^a   Qian, David Z ^a   Beer, Tomasz M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; PROTEIN P21; PROTEIN P53; HOMEODOMAIN PROTEIN; IRX5 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; VITAMIN;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL STRAIN HCT116; CELL STRAIN LNCAP; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE CONTROL; HOMEOBOX; HUMAN; HUMAN CELL; IRX5 GENE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RNA INTERFERENCE; BREAST TUMOR; CELL CYCLE; COLON TUMOR; DOWN REGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CALCITRIOL; CELL CYCLE; CELL LINE, TUMOR; COLONIC NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; MALE; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; VITAMINS;

EID: 50349097387     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-4649     Document Type: Article

References (49)

1. Guyton KZ, Kensler TW, Posner GH. Vitamin D, vitamin D. analogs as cancer chemopreventive agents. Nutr Rev 2003;61:227-38.
2. Johnson CS, Hershberger PA, Bernardi RJ, McGuire TF, Trump DL. Vitamin D receptor: a potential target for intervention. Urology 2002;60:123-30; discussion 30-1.
3. Guzey M, Kitada S, Reed JC. Apoptosis induction by 1α25- dihydroxyvitamin D3 in prostate cancer. Mol Cancer Ther 2002;1:667-77.
4. Modzelewski RA, Hershberger PA, Johnson CS, Trump DL. Apoptotic effects of paclitaxel and calcitriol in rat dunning MLL and human PC-3 prostate tumors in vitro. Proc AACR 1999;40:580.
5. Pepper C, Thomas A, Hoy T, Milligan D, Bentley P, Fegan C. The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood 2003;101:2454-60.
6. Bektas M, Orfanos CE, Geilen CC. Different vitamin D analogues induce sphingomyelin hydrolysis and apoptosis in the human keratinocyte cell line Ha CaT. Cell Mol Biol (Noisy-le-grand) 2000;46:111-9.
7. Bernardi RJ, Trump DL, Yu WD, McGuire TF, Hershberger PA, Johnson CS. Combination of 1 α25- dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res 2001;7:4164-73.
8. McGuireTF, Trump DL, Johnson CS. Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem 2001;276:26365-73.
9. Bernardi R, Johnson CS, Modzelewski RA, Trump, DL. Antiproliferative effects of 1 α25-dihydroxyvitamin D3 and vitamin D analogs on tumor-derived endothelial cells. Endocrinology 2002;143:2508-14.
10. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1 α25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 2000;87:214-20.
11. Majewski S, Skopinska M, Marczak M, Szmurlo A, Bollag W, Jablonska S. Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis. J Investig Dermatol Symp Proc 1996;1:97-101.
12. Getzenberg RH, Light BW, Lapco PE, et al. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology 1997;50:999-1006.
13. Schwartz GG, Wang MH, Zhang M, Singh RK, Siegal GP. 1α25- dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 1997;6: 727-32.
14. Sung V, Feldman D. 1.25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration. Mol Cell Endocrinol 2000;164:133-43.
15. Dambly-Chaudiere C, Leyns L. The determination of sense organs in Drosophila: a search for interacting genes. Int J Dev Biol 1992;36:85-91.
16. Leyns L. Gomez-Skarrneta JL, Dambly-Chaudiere C. iroquois: a prepattern gene that controls the formation of bristles on the thorax of Drosophila. Mech Dev 1996;59:63-72.
17. Bellefroid EJ, Kobbe A, Gruss P, Pieler T, Gurdon JB, Papalopulu N. Xiro3 encodes a Xenopus homolog of the Drosophila Iroquois genes and functions in neural specification. EMBO J 1998;17:191 -203.
18. Bosse A, Stoykova A, Nieselt-Struwe K, et al. Identification of a novel mouse Iroquois homeobox gene, Ir×5. and chromosomal localisation of all members of the mouse Iroquois gene family. Dev Dyn 2000;218:160-74
19. Gomez-Skarmeta JL, Glavic A, de la Calle-Mustienes E, Modolell J, Mayor R. Xiro, a Xenopus homolog of the Drosophila Iroquois complex genes, controls development at the neural plate. EMBO J 1998;17181 -90.
20. Goriely A, Diez del Corral R, Storey KG. c-lr×2 expression reveals an early subdivision of the neural plate in the chick embryo. Mech Dev 1999;87:203-6.
21. Peters T Dildrop R, Ausmeier K, Ruther U, Organization of mouse Iroquois homeobox genes in two clusters suggests a conserved regulation and function in vertebrate development. Genome Res 2000;10:1453-62.
22. Gomes-Skarmeta JL, Diez del Corral R, de la Calle- Mustiennes E, Ferres-Marco D, Modolell J. araucan and caupolican, two members of the novel Iroquois complex, encode homeoproteins that control proneural and vein-forming genes. Cell 1996;85:95-105.
23. Wang GF, Nikovits W, Jr., Bao ZZ, Stockdale FE Ir×4 forms an inhibitory complex with the vitamin D, retinoic X. receptors to regulate cardiac chamber-specific slow MyHC3 expression. J Biol Chem 2001;276:28835-41.
24. Kudoh T, Dawid IB. Role of the iroquois3 homeobox gene in organizer formation. Proc Natl Acad Sci U S A 2001;98:7852-7.
25. Bilioni A, Craig G, Hill C, McNeill H. Iroquois transcription factors recognize a unique motif to mediate transcriptional repression in vivo. Proc Natl Acad Sci U S A 2005;102:14671-6.
26. Stuart ET, Yokota Y, Gruss P. PAX and HOX in neoplasia. Adv Genet 1995;33:255-74.
27. DeVita G, Barba P, Odartchenko N, et al. Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer 1993;29A:887-93.
28. Friedmann Y, Daniel CA, Strickland P, Daniel CW. Hox genes in normal and neoplastic mouse mammary gland. Cancer Res 1994;54:5981-5.
29. Abate-Shen C. Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2002;2:777-85.
30. Del Bene F, Wittbrodt J. Cell cycle control by homeobox genes in development and disease. Semin Cell Dev Biol 2005;16:449-60.
31. Chen H, Sukumar S. Role of homeobox genes in normal mammary gland development and breast tumorigenesis. J Mammary Gland Biol Neoplasia 2003;8:159-75.
32. Lohmann I, McGinnis N. Bodmer M, McGinnis W. The Drosophila Hox gene deformed sculpts head morphology via direct regulation of the apoptosis activator reaper. Cell 2002;110:457-66.
33. Daftary GS, Taylor HS. Endocrine regulation of HOX genes. Endocr Rev 2006;27:331-55.
34. Beer TM, Myrthue A, Garzotto M, et al. Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2004;13:2225-32.
35. Iwao K, Miyoshi Y Egawa C, Ikeda N, Noguchi S. Quantitative analysis of estrogen receptor-β mRNA and its variants in human breast cancers. Int J Cancer 2000;88:733-6
36. Duriez PJ, Shah GM. Cleavage of poly(ADP-nbose) polymerase: a sensitive parameter to study cell death Biochem Cell Biol 1997;75:337-49.
37. van Tuyl M, Liu J, Groenman F. et al Iroquois genes influence proximo-distal morphogenesis during rat lung development. Am J Physiol Lung Cell Mol Phys iol 2006;2901777-89.
38. Gartel AL.Tyner AL. Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 1999;246:280-9.
39. Gartel AL. Tyner AL. The role of the cyclm-dependent kinase inhibitor p21 in apoptosis Mol Cancer Ther 2002;1:639-49.
40. Martin-Caballero J, Flores JM, Garcia-Palencia P. Serrano M. Tumor susceptibility of p21 (Waf1 Cip1)-deficient mice. Cancer Res 2001;61:6234-8
41. Maki CG, Howley PM. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol Cell Biol 1997;17:355-63.
42. Sheaff RJ. Singer JD. Swanger J. Smitherman M. Roberts JM. Clurman BE. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination Mol Cell 2000;5:403-10.
43. Touitou R, Richardson J. Bose S. Nakanishi M. Rivett J. Allday MJ. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 α-subunit of the 20S proteasome. EMBO J 2001;20:2367 - 75.
44. Roninson IB. Oncogenic functions of tumour suppressor p21 (Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 2002;179:1 - 14.
45. 2-M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication Mol Cell Biol 1998;18:629-43.
46. Ogryzko VV, Wong P. Howard BH. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol Cell Biol 1997;17:4877-82.
47. Gidekel S, Pizov G. Bergman Y Pikarsky E. Oct-3 4 is a dose-dependent oncogenic fate determinant Cancer Cell 2003:4:361-70
48. de la Calle-Mustienes E, Glavic A, Modolell J, Gomez-Skarmeta JL. Xiro homeoprotems coordinate cell cycle exit and primary neuron formation by upregulating neuronal-fate repressors and downregulating the cell-cycle inhibitor XGadd45-.γ Mech Dev 2002;119:69-80.
49. Cheng CW. Chow RL. Lebel M. et al. The Iroquois homeobox gene, Ir×5, is required for retinal cone bipolar cell development. Dev Biol 2005;287:48 - 60.